Discover
SUPN
Supernus Pharmaceuticals, Inc.
48.49
3 x 48.49
1 x 48.54
bid
ask
+
1.42
3.02%
01:40 PM
timesize
| Ytd | -2.43% | |
| 1y | 19.53% |
47.01
day range
48.57
40.50
52 week range
59.68
| Open | 47.59 | Prev Close | 47.07 | Low | 47.01 | High | 48.57 | Mkt Cap | 2.82B |
| Vol | 186.61K | Avg Vol | 853.85K | EPS | 3.06 | P/E | 15.85 | Forward P/E | 10.68 |
| Beta | 0.56 | Short Ratio | 4.88 | Inst. Own | 104.10% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 46.18 | 200-d Avg | 48.90 | 1yr Est | 61.75 |
| Income Statement | |||
| Total Revenue | 219.06M | ||
| Revenues (USD) | 219.06M | ||
| Cost of Revenue | 33.67M | ||
| Gross Profit | 185.39M | ||
| Operating Expenses | 243.35M | ||
| Research and Development Expense | 29.46M | ||
| Selling, General and Administrative Expense | 133.64M | ||
| Operating Income | -57.96M | ||
| Interest Expense | 2.32M | ||
| Income Tax Expense | 723.00K | ||
| Net Income | -58.37M | ||
| Net Income Common Stock | -58.37M | ||
| Net Income Common Stock (USD) | -58.37M | ||
| Consolidated Income | -58.37M | ||
| Earnings per Basic Share | -1.01 | ||
| Earnings per Basic Share (USD) | -1.01 | ||
| Earnings per Diluted Share | -1.01 | ||
| Earning Before Interest & Taxes (EBIT) | -55.33M | ||
| Earning Before Interest & Taxes (USD) | -55.33M | ||
| Weighted Average Shares | 58.07M | ||
| Weighted Average Shares Diluted | 58.07M | ||
| Balance Sheet | |||
| Cash and Equivalents | 181.40M | ||
| Cash and Equivalents (USD) | 181.40M | ||
| Investments | 192.11M | ||
| Investments Current | 192.11M | ||
| Trade and Non-Trade Receivables | 211.66M | ||
| Current Assets | 723.50M | ||
| Property, Plant & Equipment Net | 10.20M | ||
| Total Assets | 1.43B | ||
| Total Debt | 29.43M | ||
| Current Liabilities | 347.38M | ||
| Debt Non-Current | 29.43M | ||
| Total Liabilities | 396.88M | ||
| Accumulated Retained Earnings (Deficit) | 457.21M | ||
| Accumulated Other Comprehensive Income | -138.00K | ||
| Shareholders Equity | 1.03B | ||
| Shareholders Equity (USD) | 1.03B | ||
| Assets Non-Current | 704.61M | ||
| Total Debt (USD) | 29.43M | ||
| Goodwill and Intangible Assets | 588.89M | ||
| Inventory | 83.92M | ||
| Liabilities Non-Current | 49.51M | ||
| Trade and Non-Trade Payables | 108.46M | ||
| Tax Assets | 49.06M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 27.94M | ||
| Net Cash Flow from Financing | -7.20M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.92M | ||
| Capital Expenditure | -568.00K | ||
| Issuance (Purchase) of Equity Shares | 4.12M | ||
| Net Cash Flow from Investing | 7.09M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 7.66M | ||
| Net Cash Flow from Operations | -4.81M | ||
| Share Based Compensation | 8.64M | ||